Concepedia

Author

TracyAnn Perry

National Institute on Aging

Also Known As

T Perry, T. A. Perry, T.A. Perry, TracyAnn Perry, Tracyann Perry

16

Publications

2.8K

Citations

13

H-Index

22

Concepts

All Affiliations

National Institute on AgingNational Institutes of HealthIndiana University – Purdue University Indianapolis
TP

About

TracyAnn Perry is an author at National Institute on Aging specializing in medicine, neuroscience, and neurochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

984

2

Neuroscience

4

4

984

3

Health Sciences

1

1

331

4

Social Sciences

1

1

184

5

Neurology

1

1

408

TracyAnn Perry

×

8

Publications

2K

Citations

8

H-Index

YearCitations

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

Nigel H. Greig, Tada Utsuki, Qian‐sheng Yu,

Current Medical Research and Opinion

2001

408

Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4

TracyAnn Perry, Norman J. Haughey, Mark P. Mattson,

Journal of Pharmacology and Experimental Therapeutics

2002

370

Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system

E.M. Torres, TracyAnn Perry, A. Blokland,

Neuroscience

1994

331

GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

Yazhou Li, Kara B. Duffy, Mary Ann Ottinger,

Journal of Alzheimer s Disease

2010

319

A Novel Neurotrophic Property of Glucagon-Like Peptide 1: A Promoter of Nerve Growth Factor-Mediated Differentiation in PC12 Cells

TracyAnn Perry, Debomoy K. Lahiri, De‐Mao Chen,

Journal of Pharmacology and Experimental Therapeutics

2002

295

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

TracyAnn Perry, Harold W. Holloway, Ananda Weerasuriya,

Experimental Neurology

2006

184

The experimental Alzheimer drug phenserine: preclinical pharmacokinetics and pharmacodynamics

Nigel H. Greig, E. De Micheli, Harold W. Holloway,

Acta Neurologica Scandinavica

2000

73

Behavioural, histological and immunocytochemical consequences following 192 IgG-saporin immunolesions of the basal forebrain cholinergic system

TracyAnn Perry, Helen Hodges, Jeffrey A. Gray

Brain Research Bulletin

2001

61

Page 1